Population
Type II diabetic patients
Design
Review
Authors
Loading...
May link hyperinsulinemia to thrombosis in diabetes; hypothesis-generating for targeted therapies.
Hyperinsulinemia in type II diabetes may contribute to macrovascular disease by increasing PAI-1 levels and impairing endogenous fibrinolysis, thereby promoting atherogenesis.
Schneider et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: